Cliniques Universitaires Saint-Luc

Neurodegenerative disease and brain imaging

Clinical research includes Alzheimer’s disease and related cognitive disorders, with a focus on PET/CT imaging of tau and amyloid pathology in the brain.

  • Alzheimer’s disease
  • mild cognitive impairment
  • neuroimaging biomarkers

Work in this area also covers comparison with control populations to characterise regional protein deposition patterns across neurodegenerative conditions.

Autoimmune and inflammatory disease

Trials address rheumatoid arthritis and severe allergic and eosinophilic asthma, with interest in immune-cell activity, synovial tissue biology, and inflammatory control.

  • rheumatoid arthritis
  • severe allergic and eosinophilic asthma
  • synovial biopsies

Research also examines blood-based T-cell peptide responses and immunohistochemical features linked to immune-mediated disease.

Cardiac and vascular disorders

Investigation extends to cardiac sarcoidosis and arterio-venous malformations, with emphasis on inflammatory cardiac lesions and complex vascular anomalies.

  • cardiac sarcoidosis
  • arterio-venous malformations
  • cardiac inflammation

Imaging-based assessment is used to explore lesion detection in the heart and symptom burden in refractory vascular disease.

Head and neck cancer

Oncology activity includes locally advanced head and neck squamous cell carcinoma and squamous cell carcinoma of the head and neck, with attention to immune markers and residual disease assessment.

  • locally advanced head and neck squamous cell carcinoma
  • HPV-negative head and neck cancer
  • ctDNA-positive disease

Research also involves peptide-based immunotherapy and PD-L1-associated treatment selection in this tumour group.

Renal cancer

Studies in metastatic clear cell renal carcinoma focus on PSMA imaging and treatment response assessment in advanced kidney cancer.

  • metastatic clear cell renal carcinoma
  • PSMA PET/CT
  • treatment response biomarkers

This area reflects interest in using molecular imaging to characterise disease activity and support evaluation of anticancer therapy.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Brain Imaging for Alzheimer’s Disease Using Florquinitau (18F) in Patients with Mild Cognitive Impairment and Early Alzheimer’s Symptoms

    Recruiting

    4 1 1
    Investigated drugs:
    Belgium
  • Study of Sarilumab for Patients with Rheumatoid Arthritis Not Responding to Anti-TNF Therapy

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study of ezabenlimab in patients with locally advanced head and neck cancer who have remaining signs of disease after chemoradiotherapy

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study on the Safety and Effectiveness of Regorafenib for Patients with Arterio-Venous Malformations Unresponsive to Standard Treatment

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    Belgium
  • Study on the Effectiveness of Early PSMA-PET Scans with Gozetotide in Patients with Metastatic Renal Cancer Undergoing Standard Immunotherapy

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    Belgium
  • Detecting Heart Inflammation in Cardiac Sarcoidosis Patients Using 68Ga-NOTA-Anti-MMR-VHH2 PET-CT Imaging

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Belgium